Get in Touch
0
0

Insights Blog

Explore our thought leadership insights, as life science technologies evolve and accelerate.
Filters
Reset All
Search
Industries
Insight Type
Topics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Newsletter Update
Pharma & Biotech
Digital Health | Q1 2023 Update
The first quarter has wrapped, and there are developments from 510(k) approvals to a Nuance and Microsoft partnership, and fruits of a Google and Mayo Clinic partnership to dive into. We bring you the most relevant snippets in digital health.
May 2, 2023
Newsletter Update
Pharma & Biotech
Digital Health | Q1 2023 Update
The first quarter has wrapped, and there are developments from 510(k) approvals to a Nuance and Microsoft partnership, and fruits of a Google and Mayo Clinic partnership to dive into. We bring you the most relevant snippets in digital health.
May 2, 2023
Health Technology Market
Medical Devices
Digital Health
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | April Roundup 2023
Read our latest newsletter, recapping major developments in the Next-Generation Therapeutics space in the month of April.
May 1, 2023
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | April Roundup 2023
Read our latest newsletter, recapping major developments in the Next-Generation Therapeutics space in the month of April.
May 1, 2023
Next-Generation Therapeutics
Regulatory
Infographic
Clinical Diagnostics
How do NGS labs that offer multiple solid-tumor panels today expect their testing to shift over the next few years?
Our latest analysis dives into the dynamics between small and large solid tumor panel volumes.
May 1, 2023
Infographic
Clinical Diagnostics
How do NGS labs that offer multiple solid-tumor panels today expect their testing to shift over the next few years?
Our latest analysis dives into the dynamics between small and large solid tumor panel volumes.
May 1, 2023
Clinical Diagnostics
Diagnostics Market
Immuno-Oncology
Liquid Biopsy
In The Press
How next-generation sequencing is informing oncology drug discovery
Listen to our latest webinar sponsored by Tecan where some of our experts discuss next generation sequencing and its role in drug discovery.
April 24, 2023
In The Press
How next-generation sequencing is informing oncology drug discovery
Listen to our latest webinar sponsored by Tecan where some of our experts discuss next generation sequencing and its role in drug discovery.
April 24, 2023
No items found.
DeciBio News
Clinical Diagnostics
DeciBio Analytics launches the refreshed 2023 NGS Oncology DxBook
The new NGS Oncology DxBook provides a more vivid picture of clinical labs’ NGS oncology testing behaviors.
April 6, 2023
DeciBio News
Clinical Diagnostics
DeciBio Analytics launches the refreshed 2023 NGS Oncology DxBook
The new NGS Oncology DxBook provides a more vivid picture of clinical labs’ NGS oncology testing behaviors.
April 6, 2023
Clinical Diagnostics
Diagnostics Market
Immuno-Oncology
Liquid Biopsy
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | March Roundup
Learn about new insurance coverage for MRD, partnerships, and several funding and trial announcements in the Liquid Biopsy space in our latest newsletter.
April 5, 2023
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | March Roundup
Learn about new insurance coverage for MRD, partnerships, and several funding and trial announcements in the Liquid Biopsy space in our latest newsletter.
April 5, 2023
Liquid Biopsy
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch
© DeciBio 2023 | All rights reserved
Privacy
Terms & Conditions